Humira, a new biologic therapy for rheumatoid arthritis
January 2005
Health Canada has approved Humira, a new biologic therapy for rheumatoid arthritis.
Humira (adalimumab) works similar to Remicade (infliximab) and Enbrel (etanercept). These block tumor necrosis factor alpha, or TNF-alpha.
People with rheumatoid arthritis have too much TNF-alpha that attacks bones, cartilage, and joints...leading to inflammation.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive